Marriage Counselors in Gladstone, OR Accepting Medicare
4 Marriage Counselors found. Showing 1 - 4
 Jennifer Lynn Pitt, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 890 82nd Dr, Gladstone, OR 97027 Phone: 503-233-5405 |
 Ryan Michael Wilcox, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 880 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515 |
Jennifer Michelle Roholt Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 18911 Portland Ave, Gladstone, OR 97027 Phone: 503-556-8471 Fax: 503-722-6810 |
Jill Denise Henion, MMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 880 82nd Dr, Gladstone, OR 97027 Phone: 503-659-5515 Fax: 503-233-2694 |
News Archive
Plastic surgeries in the US surge due to increase in weight loss surgeries
An increase in the number of weight loss surgeries in the U.S. is beginning to have a ripple effect in plastic surgery, according to new data released today by the American Society of Plastic Surgeons (ASPS). Procedures specifically associated with massive weight loss, including tummy tucks, thigh lifts, breast lifts and upper arm lifts, grew at their fastest rate in four years in 2014, according to the report. That follows a similar increase in the growth of weight loss surgeries.
Researchers reveal how tumor cells disrupt circadian rhythm to survive
Tumor cells use the unfolded protein response to alter circadian rhythm, which contributes to more tumor growth, Hollings Cancer Center researchers at the Medical University of South Carolina find.
AB Science announces results from masitinib phase 2 study on MS
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of results from the human phase 2 study of masitinib carried-out in the treatment of progressive multiple sclerosis.
EMEA PDCO recommends Cell Therapeutics to submit updated Pediatric Investigation Plan for pixantrone
Cell Therapeutics, Inc. today announced the European Medicines Agency Pediatric Committee recommended the Company submit an updated Pediatric Investigation Plan for pixantrone following discussions with the Company about the preclinical and clinical pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may offer to children with hematologic cancer.
FDA issues CRL to Repligen's RG1068 NDA for treatment of pancreatitis
Repligen Corporation today announced that it has received a Complete Response Letter (CRL) from the U.S. Food & Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for RG1068.
› Verified 8 days ago
Counselors
Psychologists
Clinical Social Workers
Dentists
Pharmacists
Marriage Counselors